Financial Services
TurnKey Capital, Inc.(TKCI)
Live Price
Offline$0.10
+0.00% today
1Y Change
-86.84%
Window
Jun 24, 2025 → Jun 11, 2026
- Market Cap
- —
- Revenue Growth
- 0.0%
- EPS Growth
- +290.8%
- Dividend Yield
- 0.0%
Coverage: 247 bars · Jun 24, 2025 → Jun 11, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
TurnKey Capital, Inc. (TKCI) is a Financial Services stock with listed on OTC. The stock last traded around $0.10 and down 86.8% across the available one-year price window (Jun 24, 2025 → Jun 11, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +290.8%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +290.8%, free cash flow 0.0% with operating margin 26.7% and ROIC 0.0%. Valuation already assumes a fairly strong business story at P/E 3116.7 and price/sales 0.8. Stock Foundry combines TKCI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +3.4% peer median
Operating Margin
Above sector median
+26.7% vs +4.7% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is +290.8%, while operating margin sits near 26.7%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TKCI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TKCI Max Drawdown
-91.03%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for TKCI and SPY.
Company Overview
TurnKey Capital, Inc.
Other OTC
HealthSpan Medical Systems, Inc. develops marijuana based intravenous therapy (IV) infusion blends for healthcare practitioners. The company was incorporated in 2018 and is headquartered in Ft. Lauderdale, Florida.
- Leadership
- Neil Swartz
- IPO Date
- Jan 7, 2014
- Employees
- 33
- Street Address
- 3079 East Commercial Boulevard
- Mailing
- Ft. Lauderdale, FL, 33308
- Region
- Ft. Lauderdale, FL, US
- Reporting Currency
- USD
- Investor Line
- 954-676-4088
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 3116.7
- EV/EBITDA
- 2.1
- Price/Sales
- 0.8
- Price/Book
- 0.2
Growth
- Revenue
- 0.0%
- EPS
- +290.8%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 26.7%
- Net Margin
- 26.7%
- ROE
- 0.0%
- ROIC
- 0.0%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 509.95
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.